Social and Structural Determinants of Cardiovascular Complications of Diabetes

被引:0
|
作者
Mensah, Portia [1 ,2 ]
Valdez, Kelly [1 ,2 ]
Gyawali, Ankita [1 ]
Snell-Bergeon, Janet [1 ,2 ]
机构
[1] Univ Colorado Anschutz Med Campus, Barbara Davis Ctr Diabet, Mail Stop F547, Aurora, CO 80045 USA
[2] Univ Colorado Anschutz Med Campus, Colorado Sch Publ Hlth, Aurora, CO 80045 USA
关键词
Diabetes; Cardiovascular Disease; Social Determinants of Health; Disparities; Structural Determinants of Health; Type; 1; diabetes; 2; HEALTH-CARE ACCESS; SOCIOECONOMIC-STATUS; AFRICAN-AMERICANS; GLYCEMIC CONTROL; TYPE-1; MORTALITY; DISEASE; OUTCOMES; ASSOCIATION; IMPACT;
D O I
10.1007/s11892-024-01541-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose of ReviewCardiovascular disease (CVD) is the leading cause of mortality in people who have diabetes. Racial and ethnic minorities with diabetes have suboptimal management of cardiovascular risk factors, leading to higher mortality. Social and structural determinants of health are external factors that influence an individual's ability to choose positive health behaviors. In this review, we will discuss cardiovascular complications in people who have diabetes and their relationship to social determinants of health (SDOH).Recent FindingsRecent innovations in diabetes treatment, including new devices and medications, have improved care and survival. However, disparities in the availability of these treatments to racial and ethnic minorities may contribute to continued inequities in CVD outcomes.SummaryRacial/ethnic disparities in CVD relate to inequities in economic opportunity, education and health literacy, neighborhoods and social cohesion, and health care access and quality driven by structural racism.
引用
收藏
页码:147 / 157
页数:11
相关论文
共 50 条
  • [41] Postprandial hyperglycaemia and cardiovascular complications of diabetes: An update
    Ceriello, Antonio
    Davidson, Jamie
    Hanefeld, Markolf
    Leiter, Lawrence
    Monnier, Louis
    Owens, David
    Tajima, Naoko
    Tuomilehto, Jaakko
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2006, 16 (07) : 453 - 456
  • [42] Cardiovascular complications of type 2 diabetes in youth
    Kehler, D. Scott
    Stammers, Andrew N.
    Susser, Shanel E.
    Hamm, Naomi C.
    Kimber, Dustin E.
    Hlynsky, Michael W.
    Duhamel, Todd A.
    BIOCHEMISTRY AND CELL BIOLOGY, 2015, 93 (05) : 496 - 510
  • [43] Assessment of the cardiovascular and gastrointestinal autonomic complications of diabetes
    Brock, Christina
    Brock, Birgitte
    Pedersen, Anne Grave
    Drewes, Asbjorn Mohr
    Jessen, Niels
    Farmer, Adam D.
    WORLD JOURNAL OF DIABETES, 2016, 7 (16): : 321 - 332
  • [44] Cardiovascular complications in type 1 diabetes mellitus
    Brindisi, M. -C.
    Bouillet, B.
    Verges, B.
    Halimi, S.
    DIABETES & METABOLISM, 2010, 36 (05) : 341 - 344
  • [45] Epidemiology of cardiovascular complications in diabetes mellitus.
    Grimaldi, A
    Heurtier, A
    DIABETES & METABOLISM, 1999, 25 : 12 - 20
  • [46] IL-6 in diabetes and cardiovascular complications
    Qu, Dan
    Liu, Jian
    Lau, Chi Wai
    Huang, Yu
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (15) : 3595 - 3603
  • [47] Role of microRNAs in diabetes and its cardiovascular complications
    Shantikumar, Saran
    Caporali, Andrea
    Emanueli, Costanza
    CARDIOVASCULAR RESEARCH, 2012, 93 (04) : 583 - 593
  • [48] Role of peroxynitrite in the pathogenesis of cardiovascular complications of diabetes
    Pacher, P
    Szabó, C
    CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (02) : 136 - 141
  • [49] Cardiovascular autonomic neuropathies as complications of diabetes mellitus
    Michael Kuehl
    Martin J. Stevens
    Nature Reviews Endocrinology, 2012, 8 : 405 - 416
  • [50] Diabetes Incidence in Subjects with and without Cardiovascular Complications
    Johansen, Odd Erik
    Ofstad, Anne Pernille
    Sorensen, Monica
    Blaasaas, Karl G.
    Gullestad, Lars
    Birkeland, Kare I.
    DIABETES, 2009, 58 : A550 - A550